Showing results (1831-1840 of 1,975) with videos related to
Sort By:
Pageof 198
Equity Neuroscience|March 16, 2026
The significance of the WHO/ISH absolute cardiovascular risk prediction scores among recent stroke survivors in Ghana-Insights from the PINGS2 multicenter studyAnsumana Bockarie, Nana Kwame Ayisi-Boateng, Samuel Blay Nguah, et al.The Pan African Medical Journal|February 18, 2021
The COVID-19 pandemic: broad partnerships for the rapid scale up of innovative virtual approaches for capacity building and credible information dissemination in AfricaAmbrose Otau Talisuna, Boukare Bonkoungou, Fausta Shakiwa Mosha, et al.Hepatology (Baltimore, Md.)|February 24, 2018
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trialGraham R Foster, Kosh Agarwal, Matthew E Cramp, et al.The Lancet. Infectious Diseases|August 22, 2025
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trialMoses R Kamya, Joaniter I Nankabirwa, Chris Ebong, et al.Plos One|June 3, 2022
Health-related quality of life among cervical cancer survivors at a tertiary hospital in GhanaKwabena Amo-Antwi, Ramatu Agambire, Thomas O Konney, et al.Journal of Hypertension|September 1, 2017
Variations in hypertension awareness, treatment, and control among Ghanaian migrants living in Amsterdam, Berlin, London, and nonmigrant Ghanaians living in rural and urban Ghana - the RODAM studyCharles Agyemang, Gertrude Nyaaba, Erik Beune, et al.Tropical Medicine and Infectious Disease|July 2, 2021
Extended Spectrum Beta-Lactamase Escherichia coli in River Waters Collected from Two Cities in Ghana, 2018-2020Regina Ama Banu, Jorge Matheu Alvarez, Anthony J Reid, et al.Annals of Internal Medicine|August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort StudyJason Grebely, Gregory J Dore, Frederick L Altice, et al.Journal of Medicinal Chemistry|April 24, 2018
Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated SubstitutionsWensheng Yu, Ling Tong, Oleg Selyutin, et al.Bioorganic & Medicinal Chemistry Letters|September 17, 2016
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.Pageof 198